Drugplain

Sandostatin LAR Depot

octreotide acetate · KIT · Novartis Pharmaceuticals Corporation

No Recall History
Plain English

Sandostatin Lar Depot is a long-acting injectable medication containing octreotide that is used to treat acromegaly, neuroendocrine tumors, and variceal bleeding. It works by reducing the production of certain hormones in the body.

Key Facts

Brand Name
Sandostatin LAR Depot
Generic Name
octreotide acetate
NDC Code (Product)
0078-0811
Manufacturer
Novartis Pharmaceuticals Corporation
Dosage Form
KIT
Marketing Status
Application #
NDA021008
Marketing Start
07/22/2016

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

death3,241 reports
diarrhoea2,870 reports
needle issue2,371 reports
fatigue2,273 reports
malaise2,222 reports
blood pressure increased2,065 reports
pain1,815 reports
nausea1,797 reports
malignant neoplasm progression1,748 reports
blood pressure systolic increased1,684 reports

Frequently Asked Questions

What is Sandostatin LAR Depot used for?

Sandostatin Lar Depot is a long-acting injectable medication containing octreotide that is used to treat acromegaly, neuroendocrine tumors, and variceal bleeding. It works by reducing the production of certain hormones in the body.

Is Sandostatin LAR Depot a controlled substance?

Sandostatin LAR Depot is not classified as a controlled substance by the DEA.

What is the generic name for Sandostatin LAR Depot?

The generic name for Sandostatin LAR Depot is octreotide acetate. There are 10 other brand versions of octreotide acetate.

What is the NDC code for Sandostatin LAR Depot ?

The NDC (National Drug Code) for Sandostatin LAR Depot is 0078-0811, listed by Novartis Pharmaceuticals Corporation.